Movement Alert|GeneDx Holdings Falls 5.03% in Regular Trading, Shares Continue to Digest Cautious Post-Earnings Guidance

Market Focus11-12

On November 12, GeneDx Holdings fell 5.03% in Regular Trading, trading at $52.46 per share, with turnover of $4.4317 million.

The clearest catalyst in recent public disclosures was continued pressure after the company issued cautious forward guidance alongside its latest quarterly report, even though adjusted earnings and revenue both edged past consensus estimates.

GeneDx Holdings reported adjusted EPS of $0.28 for the September quarter, above the $0.07 consensus, on revenue of $123.1 million versus expectations of $122.9 million. However, Q4 revenue guidance of $135 million came in below the $142.6 million consensus, while the company reiterated full-year revenue guidance of $475 million to $490 million rather than raising it. Post-results, Piper Sandler maintained a Buy rating with a $95 target, while BTIG kept Buy but cut its target to $85 from $90, indicating a more cautious view on near-term growth cadence.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment